Dr. Diana Born
Pathologie · Dept. IV
Fibroblastic reticular cells generate protective intratumoral T cell environments in lung cancer.
Onder L, Papadopoulou C, Lütge A, Cheng H, Lütge M, Pérez Shibayama C, Gil Cruz C, De Martin A, Kurz L, Cadosch N, Pikor N, Rodriguez R, Born D, Jochum W, Leskow P, Dutly A, Robinson M, Ludewig B. Fibroblastic reticular cells generate protective intratumoral T cell environments in lung cancer. Cell 2024
Nov 19, 2024Fibroblastic reticular cells generate protective intratumoral T cell environments in lung cancer.
Nov 19, 2024Cell 2024
Onder Lucas, Papadopoulou Chrysa, Lütge Almut, Cheng Hung-Wei, Lütge Mechthild, Pérez Shibayama Christian Ivan, Gil Cruz Cristina, De Martin Angelina, Kurz Lisa, Cadosch Nadine, Pikor Natalia, Rodriguez Regulo, Born Diana, Jochum Wolfram, Leskow Pawel, Dutly André Emanuel, Robinson Mark D, Ludewig Burkhard
[Melanosis of the bladder-a rare diagnosis].
Hagmann S, Born D, Schmid H, Rührup J. [Melanosis of the bladder-a rare diagnosis]. Urologie 2023; 62:1200-1203.
Jun 27, 2023[Melanosis of the bladder-a rare diagnosis].
Jun 27, 2023Urologie 2023; 62:1200-1203
Hagmann S, Born Diana, Schmid H P, Rührup J
in a Pediatric Patient-First Case Report from Switzerland.
Rose R, Kleitsch K, Born D, Heye P. in a Pediatric Patient-First Case Report from Switzerland. European J Pediatr Surg Rep 2023; 11:e29-e31.
May 14, 2023in a Pediatric Patient-First Case Report from Switzerland.
May 14, 2023European J Pediatr Surg Rep 2023; 11:e29-e31
Rose Rebekka, Kleitsch Kai-Uwe, Born Diana, Heye Pascal
Prediction of extranodal extension in oropharyngeal cancer patients and carcinoma of unknown primary: value of metabolic tumor imaging with hybrid PET compared with MRI and CT.
Nemmour A, Stadler T, Maurer A, Kovacs Z, Serrallach B, Born D, Nemes C, Broglie M, Pazahr S, Rupp N, Huellner M, Stöckli S, Morand G. Prediction of extranodal extension in oropharyngeal cancer patients and carcinoma of unknown primary: value of metabolic tumor imaging with hybrid PET compared with MRI and CT. Eur Arch Otorhinolaryngol 2022; 280:1973-1981.
Dec 5, 2022Prediction of extranodal extension in oropharyngeal cancer patients and carcinoma of unknown primary: value of metabolic tumor imaging with hybrid PET compared with MRI and CT.
Dec 5, 2022Eur Arch Otorhinolaryngol 2022; 280:1973-1981
Nemmour Amina, Stadler Thomas M, Maurer Alexander, Kovacs Zsofia, Serrallach Bettina, Born Diana, Nemes Constanze, Broglie Martina Anja, Pazahr Shila, Rupp Niels J, Huellner Martin W, Stöckli Sandro, Morand Grégoire B
The Role of Inorganics in Preeclampsia Assessed by Multiscale Multimodal Characterization of Placentae.
Rduch T, Tsolaki E, El Baz Y, Leschka S, Born D, Kinkel J, Anthis A, Fischer T, Jochum W, Hornung R, Gogos A, Herrmann I. The Role of Inorganics in Preeclampsia Assessed by Multiscale Multimodal Characterization of Placentae. Front Med (Lausanne) 2022; 9:857529.
Mar 30, 2022The Role of Inorganics in Preeclampsia Assessed by Multiscale Multimodal Characterization of Placentae.
Mar 30, 2022Front Med (Lausanne) 2022; 9:857529
Rduch Thomas, Tsolaki Elena, El Baz Yassir, Leschka Sebastian, Born Diana, Kinkel Janis, Anthis Alexandre H C, Fischer Tina, Jochum Wolfram, Hornung René, Gogos Alexander, Herrmann Inge K
Impact of the new TNM Staging System (8th edition) on oral tongue cancers
Ammann Y, Beutner U, Vital D, Morand G, Broglie Daeppen M, Born D, Stöckli S, Huber G. Impact of the new TNM Staging System (8th edition) on oral tongue cancers. Swiss Med Wkly 2021; 151:w20493.
May 2, 2021Impact of the new TNM Staging System (8th edition) on oral tongue cancers
May 2, 2021Swiss Med Wkly 2021; 151:w20493
Ammann Yanic, Beutner Ulrich, Vital Domenic Gian, Morand Grégoire, Broglie Daeppen Martina A, Born Diana, Stöckli Sandro, Huber Gerhard
Treatment of limited disease small cell lung cancer: the multidisciplinary team
Glatzer M, Rittmeyer A, Müller J, Opitz I, Papachristofilou A, Psallidas I, Früh M, Born D, Putora P. Treatment of limited disease small cell lung cancer: the multidisciplinary team. Eur Respir J. 2017; 50
Aug 24, 2017Treatment of limited disease small cell lung cancer: the multidisciplinary team
Aug 24, 2017Eur Respir J. 2017; 50
Glatzer Markus, Rittmeyer Achim, Müller Joachim, Opitz Isabelle, Papachristofilou Alexandros, Psallidas Ioannis, Früh Martin, Born Diana, Putora Paul Martin
Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab
Diem S, Schmid S, Krapf M, Flatz L, Born D, Jochum W, Templeton A, Früh M. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab. Lung Cancer 2017; 111:176-181.
Jul 24, 2017Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab
Jul 24, 2017Lung Cancer 2017; 111:176-181
Diem Stefan, Schmid Sabine, Krapf Mirjam, Flatz Lukas, Born Diana, Jochum Wolfram, Templeton Arnoud J, Früh Martin